SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
Status:
Terminated
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy of escitalopram compared to placebo in
reducing Acute Stress Disorder (ASD) symptoms and in preventing the emergence of
Post-Traumatic Stress Disorder (PTSD) in patients with medical trauma who are at risk for the
development of PTSD based on the presence of ASD symptoms.